These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32502839)

  • 21. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2.
    Zhang C; Xie L; Fu Y; Yang J; Cui Y
    J Cell Physiol; 2020 Nov; 235(11):7933-7944. PubMed ID: 31943174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
    Li Y
    Biochem Biophys Res Commun; 2020 Sep; 529(4):890-897. PubMed ID: 32819595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC01980 facilitates esophageal squamous cell carcinoma progression via regulation of miR-190a-5p/MYO5A pathway.
    Liang X; Wu Z; Shen S; Niu Y; Guo Y; Liang J; Guo W
    Arch Biochem Biophys; 2020 Jun; 686():108371. PubMed ID: 32325088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma.
    Huang L; Wang Y; Chen J; Wang Y; Zhao Y; Wang Y; Ma Y; Chen X; Liu W; Li Z; Zhao L; Shan B; Dong X; Li D; Shao S; Song Y; Zhan Q; Liu X
    Cell Death Dis; 2019 Jul; 10(7):513. PubMed ID: 31273188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
    Liu H; Deng H; Zhao Y; Li C; Liang Y
    J Exp Clin Cancer Res; 2018 Nov; 37(1):279. PubMed ID: 30463570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.
    Liu D; Gao M; Wu K; Zhu D; Yang Y; Zhao S
    Biomed Pharmacother; 2019 Apr; 112():108654. PubMed ID: 30784933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00473/miR-497-5p Regulates Esophageal Squamous Cell Carcinoma Progression Through Targeting PRKAA1.
    He Z
    Cancer Biother Radiopharm; 2019 Dec; 34(10):650-659. PubMed ID: 31584290
    [No Abstract]   [Full Text] [Related]  

  • 31. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3.
    Wang D; You D; Pan Y; Liu P
    Thorac Cancer; 2020 Jul; 11(7):1963-1971. PubMed ID: 32449803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of long non-coding RNA MIR31HG and its role in esophageal squamous cell carcinoma.
    Sun K; Zhao X; Wan J; Yang L; Chu J; Dong S; Yin H; Ming L; He F
    Life Sci; 2018 Jun; 202():124-130. PubMed ID: 29605445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5.
    Jiang H; Guo Y; Huang K; Lu R; Peng X; Lin S
    J BUON; 2019; 24(6):2514-2522. PubMed ID: 31983127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA LINC00467 acted as an oncogene in esophageal squamous cell carcinoma by accelerating cell proliferation and preventing cell apoptosis via the miR-485-5p/DPAGT1 axis.
    Liu Z; Yang S; Chen X; Dong S; Zhou S; Xu S
    J Gastroenterol Hepatol; 2021 Mar; 36(3):721-730. PubMed ID: 32720371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-34a reverses radiation resistance on ECA-109 cells by inhibiting PI3K/AKT/mTOR signal pathway through downregulating the expression of SIRT1.
    Ye Z; Xie T; Yan F; Wang L; Fang J; Wang Z; Hu F; Wang F; Fu Z
    Int J Radiat Biol; 2021; 97(4):452-463. PubMed ID: 33507132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G.
    Liu J; Mayekar MK; Wu W; Yan M; Guan H; Wang J; Zaman A; Cui Y; Bivona TG; Choudhry H; Xing Q; Cao W
    Cancer Lett; 2020 Nov; 493():217-227. PubMed ID: 32905814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA-IUR up-regulates PTEN by sponging miR-21 to regulate cancer cell proliferation and apoptosis in esophageal squamous cell carcinoma.
    Wang B; Hua P; Zhang L; Li J; Zhang Y
    Esophagus; 2020 Jul; 17(3):298-304. PubMed ID: 32124090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1.
    Zhang C; Wang L; Yang J; Fu Y; Li H; Xie L; Cui Y
    Eur J Pharmacol; 2019 Oct; 861():172590. PubMed ID: 31401160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
    Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
    J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.